Kanokrat Nantiruj

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 479 citations

Rheumatoid Disorder, Rheumatology, Tofacitinib Monotherapy +8

Nutritional assessment in various stages of liver cirrhosis

Chulaporn Roongpisuthipong, Abhasnee Sobhonslidsuk, Kanokrat Nantiruj et al. · Nutrition · 2001 · 143 citations

Nutrition, Body Composition, Hepatology +11

Risk factors of Pneumocystis jeroveci pneumonia in patients with systemic lupus erythematosus

Ratchaya Lertnawapan, Kitti Totemchokchyakarn, Kanokrat Nantiruj et al. · Rheumatology International · 2008 · 73 citations

Systemic Lupus Erythematosus, Lupus, Lupus Nephritis +5

Lupus nephritis and Raynaud’s phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies

Kittiwan Choojitarom, Orawan Verasertniyom, Kitti Totemchokchyakarn et al. · Clinical Rheumatology · 2007 · 47 citations

Glomerulonephritis, Autoimmune Disease, Systemic Lupus Erythematosus +12

Vitamin D receptor gene BsmIpolymorphisms in Thai patients with systemic lupus erythematosus

Wilaiporn Sakulpipatsin, Oravan Verasertniyom, Kanokrat Nantiruj et al. · Arthritis Research & Therapy · 2006 · 44 citations · Full text